Schedule 13D ownership disclosure
DICERNA PHARMACEUTICALS INC
Security class unavailable · CUSIP: 253031108
Event date: 2019-11-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-297616
- Form type
- SC 13D
- Filer
- Bain Capital Life Sciences Fund, L.P.
- CIK
- CIK 1687968
- Filed
- Nov 21, 2019
- Reporting period
- Nov 19, 2019
- Description
- Schedule 13D beneficial ownership